Six types of prescription drugs for treating heart disease and hypertension registered under Taiwanese pharmaceutical companies are being recalled as a precaution, as they could contain a probable carcinogen, the Food and Drug Administration (FDA) said yesterday.
The announcement came after governments in Hong Kong, Macau, the UK and several other countries ordered recalls of anti-hypertensive drugs containing valsartan produced by Zhejiang Huahai Pharmaceutical Co Ltd (浙江華海製藥公司) in China.
N-nitrosodimethylamine, a chemical classified as a probable human carcinogen based on laboratory test results, was detected in the valsartan.
Photo: CNA
The FDA on Saturday said that the recalled products registered under pharmaceutical company Actavis Generics were not imported to Taiwan.
However, after a preliminary examination of drugs containing valsartan that are registered in Taiwan, it discovered that six products contain valsartan from Huahai Pharmaceutical Co.
The products being recalled are: Valsart FC Tablet 160mg and Valsart FC Tablet 80mg registered to Standard Chemical and Pharmaceutical Co Ltd (生達化學製藥); Kovan Plus Coated Tablets 80/12.5mg registered to Macro Co Ltd (瑪科隆); Valsardin Film Coated Tablet 160mg and Valsardin Film Coated Tablet 80mg registered to Yung Shin Pharmaceutical Industrial Co (永信藥品); and Valen FC Tablet 160mg registered to Purzer Pharmaceutical Co Ltd (瑞安大藥廠).
The six products that are being recalled account for about 3 to 4 percent of their category in Taiwan, so the majority of heart disease patients do not have to panic, FDA official Chi Jo-feng (祁若鳳) said.
Healthcare facilities and pharmacies have been told to recall the products within a month, the FDA said, adding that patients taking the recalled drugs should not to stop taking them, but rater see a doctor as soon as possible for an alternative prescription.
Civil society groups yesterday protested outside the Legislative Yuan, decrying Chinese Nationalist Party (KMT) efforts to pass three major bills that they said would seriously harm Taiwan’s democracy, and called to oust KMT caucus whip Fu Kun-chi (傅?萁). It was the second night of the three-day “Bluebird wintertime action” protests in Taipei, with organizers announcing that 8,000 people attended. Organized by Taiwan Citizen Front, the Economic Democracy Union (EDU) and a coalition of civil groups, about 6,000 people began a demonstration in front of KMT party headquarters in Taipei on Wednesday, organizers said. For the third day, the organizers asked people to assemble
POOR IMPLEMENTATION: Teachers welcomed the suspension, saying that the scheme disrupted school schedules, quality of learning and the milk market A policy to offer free milk to all school-age children nationwide is to be suspended next year due to multiple problems arising from implementation of the policy, the Executive Yuan announced yesterday. The policy was designed to increase the calcium intake of school-age children in Taiwan by drinking milk, as more than 80 percent drink less than 240ml per day. The recommended amount is 480ml. It was also implemented to help Taiwanese dairy farmers counter competition from fresh milk produced in New Zealand, which is to be imported to Taiwan tariff-free next year when the Agreement Between New Zealand and
A woman who allegedly spiked the food and drinks of an Australian man with rat poison, leaving him in intensive care, has been charged with attempted murder, the Taipei District Prosecutors’ Office said yesterday. The woman, identified by her surname Yang (楊), is accused of repeatedly poisoning Alex Shorey over the course of several months last year to prevent the Australian man from leaving Taiwan, prosecutors said in a statement. Shorey was evacuated back to Australia on May 3 last year after being admitted to intensive care in Taiwan. According to prosecutors, Yang put bromadiolone, a rodenticide that prevents blood from
A Japanese space rocket carrying a Taiwanese satellite blasted off yesterday, but was later seen spiraling downward in the distance as the company said the launch attempt had failed. It was the second attempt by the Japanese start-up Space One to become the country’s first private firm to put a satellite into orbit, after its first try in March ended in a mid-air explosion. This time, its solid-fuel Kairos rocket had been carrying five satellites, including one from the Taiwan Space Agency and others designed by Japanese students and corporate ventures. Spectators gathered near the company’s coastal Spaceport Kii launch pad in Japan’s
RSS